...
首页> 外文期刊>Advanced drug delivery reviews >Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract
【24h】

Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract

机译:用于胃肠道核酸治疗的多隔室口服给药系统

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Gene and RNA interference therapies have significant potential for alleviating countless diseases, including many associated with the gastro-intestinal (GI) tract. Unfortunately, oral delivery of genes and small interfering RNA (siRNA) is very challenging due to the extracellular and intracellular barriers. In this review, we discuss the utilization of multi-compartmental delivery systems for oral administration of nucleic acid therapies. Some of the illustrative examples of multi-compartmental systems include solid nanoparticles-in-microsphere, solid nanoparticles-in-emulsion, and liquid nanoparticles-in-emulsion. Using type B gelatin nanoparticles encapsulated in poly(ε-caprolactone) microspheres, we have prepared nanoparticles-in-microsphere oral system (NiMOS) for gene and siRNA delivery for the treatment of inflammatory bowel disease (IBD). The results of these studies show that the multi-compartmental formulations can overcome many of the barriers for effective oral gene and siRNA delivery.
机译:基因和RNA干扰疗法在缓解无数疾病(包括与胃肠道(GI)相关的许多疾病)方面具有巨大潜力。不幸的是,由于细胞外和细胞内的屏障,基因和小干扰RNA(siRNA)的口服递送非常具有挑战性。在这篇综述中,我们讨论了将多隔室递送系统用于核酸疗法的口服给药。多隔室系统的一些说明性示例包括微球中的固体纳米颗粒,乳剂中的固体纳米颗粒和乳剂中的液体纳米颗粒。使用封装在聚(ε-己内酯)微球中的B型明胶纳米颗粒,我们制备了微球纳米颗粒口服系统(NiMOS),用于基因和siRNA递送,用于治疗炎症性肠病(IBD)。这些研究结果表明,多室制剂可以克服有效口服基因和siRNA传递的许多障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号